Catalyst Wire Dossier Catalyst Wire Dossier

PRO 2000/5

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PRO 2000/5, covering 2021-11-08 to 2021-11-08. Get the full timeline:

Most recent: Clinical Trial Update: BufferGel and PRO 2000/5: Vaginal Gels to Prevent HIV Infection in Women [Phase 2]

See pricing